Numerous studies have ascertained the crucial role played by the aberrant expression of CD147 in cancer progression, demonstrating the potential application of CD147 not only as a potential diagnostic marker of the disease [39], but also as an effective therapeutic target for the development of new anticancer therapies (Table 2). This evidence concerns the gene BSG and cancer.